Production
Pharma
Dispensaries
Investors
Sales and Operations
Consumer
Events and Networking
Politics and Law
Production
Pharma
Dispensaries
Investors
Sales and Operations
Consumer
Events and Networking
Politics and Law
Featured Articles
Following Five Years of Medical Cannabis, Germany is Poised to be the Adult-Use Capital of Europe
Germany celebrated the fifth anniversary of medical cannabis legalization. It has been an eventful five years with plenty of challenges and limitations to navigate, overcome and learn from. During the five-year run, Germany’s medical cannabis market has experienced...
Budget deal is latest sign of Democrats’ empty weed promises
Fourteen months after taking control of the federal government, they’ve done nothing to loosen federal marijuana restrictions. On the brink of gaining control in Washington, Sen. Chuck Schumer said emphatically in 2020 that “I am going to do EVERYTHING I can to end...
Georgia tries to find way out of medical marijuana impasse
They’ve found no relief, despite a state law passed three years ago that authorized six companies to sell cannabis oil to doctor-approved patients. Georgia legislators are trying to break the bureaucratic deadlock of their own creation, with protests and...
Proposal to protect workers from getting fired for off-the-job marijuana use advances with Illinois lawmakers
A proposal to prohibit firing workers for trace amounts of marijuana in their systems moved closer to passage when the Illinois House of Representatives approved the measure earlier this month — but employers remain very leery about it. The chief sponsor, state Rep....
Michigan Colleges Poised To Lead Marijuana Education In America If DEA Agrees
Michigan’s Marijuana Regulatory Agency (MRA) recently created a new license type that allows universities to purchase or produce their own cannabis for educational purposes. However, since cannabis is still federally illegal, and universities often depend on accepting...
Bipartisan Majorities In Maryland Support Marijuana Legalization, Far Outpacing Biden’s Approval In New Poll
As marijuana legalization legislation advances in Maryland, a new poll shows that there’s majority support for the reform among adults, including most Republicans. And support for legalization far outpaces President Joe Biden’s job performance approval rating in the...
Featured Articles
Congressional Memo Touts Marijuana Momentum In 2021 And Lays Out 2022 Reform Priorities
With several new states having legalized marijuana in 2021—in addition to some modest congressional developments—reform advocates put some wins on the board this year. Now a congressional memo is laying out priorities to build upon those successes for 2022. Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA), longstanding champions of reform, released the memo on behalf of the Congressional Cannabis Caucus that they co-chair. It lists the numerous pieces of marijuana legislation that have been filed this on Capitol Hill this session, including some that did advance, and then explains what to watch for next year. While the lawmakers’ memo—which was shared exclusively with Marijuana Moment ahead of its release—highlights momentum that has developed behind cannabis reform in the House this year, it also notes that the Senate still has a lot of work to do. In the meantime, arguably the most consequential reforms of 2021 did not take place in Congress. Instead, as the new report acknowledges, it was the record number of states that legalized marijuana for adult use, as well as Alabama legalizing medical cannabis.
Kyle Jaeger, Marijuana Moment, 12/15/2021 19:00:00
Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees
City officials approved municipal provisions this week suspending pre-employment drug screenings for public employees in non-safety sensitive positions. The policy change — which took immediate effect — was campaigned for by Baltimore’s mayor, Brandon M. Scott, who said: “[O]utdated and costly pre-employment drug and alcohol screenings only served to block qualified and passionate residents from obtaining employment with the City. … I am grateful that we are making this change now so that we can continue to improve local government operations and better serve the people of Baltimore.” According to reporting in The Baltimore Sun, “Pre-employment drug testing still [will] apply for so-called positions of trust, which includes jobs responsible for children, the safety of others, money or sensitive materials. Hires for senior city staff, such as department and agency heads, also would be subject to such testing.” The new policy is known as Administrative Manual Policy 205-8.
NORML, 12/15/2021 19:00:00
German Company in Talks With Afghanistan On Cannabis Cultivation
It all began with a Nov. 24 tweet (in English) from the Ministry of Interior Affairs of the Taliban’s “Islamic Emirate of Afghanistan,” declared after the militant group seized control of the country in August. It stated that the deputy minister for counter-narcotics “met with a representative” of a corporation called Cpharm, which is to “invest $450 million in setting up a hashish-processing company in Afghanistan.” The tweet stated that “medicines and creams” are to be manufactured at the facility (indicating that the word “hashish” was being used as an imprecise stand-in for cannabis). It added: “The project will be officially launched soon and hundreds of people will get job opportunities on the project.” That same day, a report by Kabul-based Pajhwok Afghan News quoted an Interior Ministry representative, Qari Saeed Khosti, making the same announcement. Regarding the outlawed status of cannabis in the country, Khosti said: “It is grown nationwide and we want to set a legal framework for sowing this illicit crop.” This report initially identified Cpharm as an Australian firm. This was later corrected, and it was changed to German. Khosti made the correction on Twitter, saying “Our talks were not with…an Australian company, but a German company.” The confusion seems to be due to the fact that the Australian Cpharm is the first to readily pop up on Google. But Khosti’s tweeted correction only went out in Pashto—not in English.
Cannabis Now, Cannabis Now, 12/17/2021 01:23:00
Bill to expand medical marijuana program passes Ohio Senate
More Ohio dispensaries could sell medical marijuana, cultivators could grow more of it, and more conditions would qualify for using it under legislation passed Wednesday by the Republican-led state Senate. The measure also calls for regulation of medical marijuana dispensaries to move from the pharmacy board to a new Division of Marijuana Control in the Commerce Department. The legislation now moves to the state House. Republican Rep. Steve Huffman, the Tipp City physician who proposed the changes, said they’re aimed at improving the program developed since Ohio legalized medical marijuana in 2016. The legislation outlines a goal of one dispensary for every 1,000 of the first 300,000 registered patients, then adding more dispensaries as needed. The list of conditions qualifying for treatment with marijuana would expand to include terminal illness, Autism spectrum disorder, chronic muscle spasms, and opioid use disorder.
Mmp News Author, Medical Marijuana Program Connection, 12/15/2021 23:58:00
Open article: https://mmpconnect.com/bill-to-expand-medical-marijuana-program-passes-ohio-senate/
Pot producer Canopy to sell German pharma unit C3 on COVID-19 hit
Canadian pot producer Canopy Growth Corp (WEED.TO), said on Wednesday it would sell its German pharmaceuticals unit, C3 Cannabinoid Compound Co GmbH, to a local firm as revenue took a hit due to pandemic-related restrictions in the country. Shares of Canopy were down 3.4% at C$8.85 in afternoon trading.The Ontario-based company said it would get an upfront payment of about C$115.5 million ($89.51 million) from German pharmaceutical firm Dermapharm Holding SE (DMPG.DE) once the deal closes in January, and up to C$61.4 million in a milestone-based payment. That is lower than the C$342.9 million Canopy paid in 2019 to buy C3, which it had often described as “transformational” to its business. Recent COVID-19 lockdown measures in Germany due to soaring virus cases restricted people’s ability to visit doctors and pharmacies, and dented C3’s revenue in the past few quarters. Sales in the unit fell 13% to C$11.9 million, according to Canopy’s second-quarter earnings report
Cannabis Business Executive – Cannabis and Marijuana industry news, 12/16/2021 08:24:00
Virginia General Assembly panel votes to recommend speeding up retail marijuana sales to 2023
The General Assembly’s Cannabis Oversight Commission has agreed to recommend that Virginia speed up the timeline for retail sales of recreational marijuana to 2023. Under a Democratic-controlled state legislature, Virginia legalized simple possession and limited home cultivation for adults earlier this year. However, retail sales were delayed until 2024, with lawmakers including a reenactment clause to the bill requiring that a second vote be held during the 2022 legislative session to move forward with the legal market. During a meeting on Thursday, members of the Cannabis Oversight Commission raised the possibility of accelerating legal sales to July 1, 2022, with the state’s Board of Pharmacy overseeing the market. Staff helping the commission informed members that the Cannabis Control Authority, the regulatory agency set up under the legislation, would need until at least 2023 to set regulations for the legal market.
Mmp News Author, Medical Marijuana Program Connection, 12/16/2021 21:42:00
Join Our Mailing List
Older Posts
VA Won’t Provide Grants For Marijuana Treatment As Part Of Proposed Veteran Suicide Prevention Initiative
The U.S. Department of Veterans Affairs (VA) is making clear it won’t provide support for treatment involving marijuana as part of a new grants program aimed at preventing veteran suicide In a notice on a proposed interim final rule for the new Staff Sergeant Parker...
Advocates Respond To Delaware House Vote On Cannabis Legalization
By Laura Sharer, Delaware NORML Dover, DE – Last week, Delaware’s House of Representatives missed another chance to legalize cannabis for adults 21 and older. HB 305 needed to clear a legislative hurdle requiring a three–fifths supermajority, or 25 votes. The final...
Key Pennsylvania Senate Committee Completes Final Marijuana Legalization Hearing To Inform Reform Legislation
News Key Pennsylvania Senate Committee Completes Final Marijuana Legalization Hearing To Inform Reform Legislation By This latest hearing marks only the third time a panel has debated recreational legalization A key Pennsylvania Senate committee on Monday held the...
Budget deal is latest sign of Democrats’ empty weed promises
That wasn’t the only weed provision left on the cutting room floor. The spending bill also failed to protect state-regulated recreational cannabis markets, nor did it expand medical marijuana research or protect veterans who use cannabis — two issues with widespread...
New York’s convicts-first approach to pot draws praise, questions
A criminal record doesn't always hurt New York state’s plan to let people with past convictions for marijuana crimes become the first to sell it legally is admirable but faces some major challenges. The dynamic pits what’s now referred to as the “legacy market” of...
Best Performing Stocks On The World’s First Marijuana ETF
Horizons Marijuana Life Sciences Index ETF (TSX:) is the world’s first Marijuana ETF. An exchange-traded fund (ETF) can be described as a basket of investments that focus on a particular asset. In the case of HMMJ, that asset is Marijuana. ETFs are traded daily at...
All Categories
Production
Pharma
Events and Networking
Dispensaries
Politics and Law
Sales and Operations
Investors
View all categories
The Indica Perspective


Always the latest news you need.
Indica News brings you all the latest information from the cannabis world. Sign up today for the latest news.
Indica News
(833) 769-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Quicklinks
Follow Us

Indica News
(833) 450-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Follow Us
Quicklinks

Indica News
(833) 450-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Follow Us
Quicklinks
